INS and type 2 diabetes mellitus: Insulin pharmacotherapy is associated with an increased risk for hypoglycaemia and weight gain; thus, its use in type 2 diabetes is typically recommended in later stages, when hyperglycaemia cannot be adequately controlled with other treatments, or when they are contraindicated [26].